You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

solanezumab

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Completed
Has Results
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +24 more
Aug 25, 2022

Cognition Disorders Trial in Worldwide (Placebo, Solanezumab)

Active, not recruiting
  • Cognition Disorders
  • Placebo
  • Solanezumab
  • Birmingham, Alabama
  • +67 more
Jan 17, 2023

Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo

Recruiting
  • Alzheimers Disease
  • +2 more
  • Birmingham, Alabama
  • +38 more
Nov 1, 2021

Healthy, Alzheimer's Disease, Mild Cognitive Impairment Trial in Japan, United States (LY2599666, Solanezumab, Placebo SC)

Terminated
Has Results
  • Healthy
  • +2 more
  • Glendale, California
  • +4 more
Jun 9, 2020

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Solanezumab
  • Placebo
  • Phoenix, Arizona
  • +192 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Solanezumab
  • Placebo
  • Phoenix, Arizona
  • +197 more
Sep 25, 2019

Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

Terminated
Has Results
  • Alzheimer's Disease
  • Solanezumab
  • Placebo
  • Phoenix, Arizona
  • +146 more
Sep 25, 2019

Alzheimer's Disease Trial in St. Louis (solanezumab)

Completed
  • Alzheimer's Disease
  • solanezumab
  • St. Louis, Missouri
    For additional information regarding investigative sites for thi
Sep 18, 2012

Alzheimer's Disease Trial in Japan (Solanezumab)

Completed
  • Alzheimer's Disease
  • Solanezumab
  • Ehime, Japan
  • +5 more
May 27, 2010